ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2018
Enhancing the Representational Power of i2b2 through Referent Tracking.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The Informatics for Integrating Biology and the Bedside (i2b2) software platform has proven successful in leveraging clinical enterprise data for the identification of cohorts of patients satisfying certain demographic, phenotypic and genetic criteria in support of further studies. An unanswered question thus far is whether i2b2 search criteria could include characteristics of assertions themselves, e.g. diagnoses, rather than what the assertions (observations) are about, e.g. diseases. This would allow, for instance, to find cohorts of patients for which different providers have been in disagreement about what condition the patient is suffering from. Previous research has shown that this requires more explicit detail about, and unique identification of, two sorts of entities: those that directly or indirectly contribute to the coming into existence of such observations and those that are either explicitly mentioned or merely implied in the assertions. Our research here demonstrates that i2b2's modifier system can be used to represent the relationships between observations and their explicit or implied referents on the one hand, and between relevant referents themselves on the other hand, both in combination with the storage of explicit unique instance identifiers for these observations and referents in i2b2's fact table. While this approach adheres to i2b2's base functionality and implementation specifications, it makes explicit ambiguities and confusions that would otherwise remain undetected.
Indexed as
Identifiers
30815064PMC6371319What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.